InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
03 April 2022 - 5:35PM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure" or the “Company”) today announced that the
Company will release financial results for its fourth quarter
fiscal 2021 ended December 31, 2021 before financial markets open
on April 4, 2022.
InterCure executives will host a live conference
call and audio webcast to discuss these results at 8:30 am Eastern
Time, details of which are provided below.
To access the conference call, United States
participants please dial (844) 310-5056, or for international
callers, 1-706-679-4749. Conference ID: 5661207.
Participants can access the live webcast through
the following link:https://bit.ly/37N92wN
A live webcast of the conference call can be
accessed on the ‘Events and Presentations’ section of the InterCure
website at http://www.intercure.co.
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From Sep 2024 to Oct 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Oct 2023 to Oct 2024